Urogenital Tract Infection

Indexed in /covered by CAS, KoreaScience & DOI/Crossref:eISSN 2012-1234   pISSN 2465-8243

Table. 1.

Table. 1.

Currently available HPV vaccinations in Korea

Characteristic Bivalent (2vHPV) Quadrivalent (4vHPV) Nanovalent (9vHPV)
Brand name Cervarix Gardasil Gardasil 9
Manufacturer GlaxoSmithKline Merck and Co, Inc. Merck and Co, Inc.
Virus-like particles 16, 18 6, 11, 16, 18 6, 11, 16, 18, 31, 33, 45, 52, 58
Injection interval
Age of 9-13 0, 6 month
Age >14 0, 2, 6 month
Age of 9-14 0, 6 month 0, 6 month
Age >15 0, 1, 6 month 0, 2, 6 month
Volume per dose 0.5 ml 0.5 ml 0.5 ml
Administration Intramuscular Intramuscular Intramuscular

HPV: human papillomavirus.

Urogenit Tract Infect 2020;15:63-70 https://doi.org/10.14777/uti.2020.15.3.63
© 2020 Urogenit Tract Infect